ES2757909T3 - Analisis de compensación que incluye señales segmentadas - Google Patents

Analisis de compensación que incluye señales segmentadas Download PDF

Info

Publication number
ES2757909T3
ES2757909T3 ES17206329T ES17206329T ES2757909T3 ES 2757909 T3 ES2757909 T3 ES 2757909T3 ES 17206329 T ES17206329 T ES 17206329T ES 17206329 T ES17206329 T ES 17206329T ES 2757909 T3 ES2757909 T3 ES 2757909T3
Authority
ES
Spain
Prior art keywords
function
sample
error
residual
compensation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17206329T
Other languages
English (en)
Spanish (es)
Inventor
Huan-Ping Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascensia Diabetes Care Holdings AG
Original Assignee
Ascensia Diabetes Care Holdings AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascensia Diabetes Care Holdings AG filed Critical Ascensia Diabetes Care Holdings AG
Application granted granted Critical
Publication of ES2757909T3 publication Critical patent/ES2757909T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Electrochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
ES17206329T 2011-09-21 2012-09-20 Analisis de compensación que incluye señales segmentadas Active ES2757909T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161537145P 2011-09-21 2011-09-21

Publications (1)

Publication Number Publication Date
ES2757909T3 true ES2757909T3 (es) 2020-04-30

Family

ID=47881000

Family Applications (2)

Application Number Title Priority Date Filing Date
ES12779189.5T Active ES2663097T3 (es) 2011-09-21 2012-09-20 Biosensor con compensación de error
ES17206329T Active ES2757909T3 (es) 2011-09-21 2012-09-20 Analisis de compensación que incluye señales segmentadas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES12779189.5T Active ES2663097T3 (es) 2011-09-21 2012-09-20 Biosensor con compensación de error

Country Status (8)

Country Link
US (2) US9775806B2 (cg-RX-API-DMAC7.html)
EP (3) EP3315123B1 (cg-RX-API-DMAC7.html)
JP (1) JP6082396B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140063829A (cg-RX-API-DMAC7.html)
ES (2) ES2663097T3 (cg-RX-API-DMAC7.html)
MX (1) MX350696B (cg-RX-API-DMAC7.html)
TW (1) TWI600892B (cg-RX-API-DMAC7.html)
WO (1) WO2013043839A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103003692B (zh) * 2010-03-22 2015-01-14 拜尔健康护理有限责任公司 用于生物传感器的剩余补偿
CA2902545A1 (en) 2013-03-14 2014-10-02 Bayer Healthcare Llc Progressive approximation of sample analyte concentration
CA2902541A1 (en) * 2013-03-14 2014-10-02 Bayer Healthcare Llc System error compensation of analyte concentration determinations
US9958410B2 (en) * 2013-03-14 2018-05-01 Ascensia Diabetes Care Holdings Ag Normalized calibration of analyte concentration determinations
WO2014160568A2 (en) * 2013-03-26 2014-10-02 Waters Technologies Corporation Method for extending the dynamic range of absorbance deterctors
GB2531728A (en) * 2014-10-27 2016-05-04 Cilag Gmbh Int Method for determining diffusion
US11644434B2 (en) 2015-05-15 2023-05-09 Ascensia Diabetes Care Holdings Ag Biosensor system analyte measurement
CA3028348A1 (en) * 2016-07-12 2018-01-18 Ascensia Diabetes Care Holdings Ag Method for electrochemical analysis by use of alternating output signals from two electrodes
JP7074753B2 (ja) * 2016-12-05 2022-05-24 アセンシア・ダイアベティス・ケア・ホールディングス・アーゲー リスク因子モニタリング
US11484876B2 (en) * 2018-12-02 2022-11-01 Polymer Technology Systems, Inc. Systems and methods for an e-gating feature in an electrochemical test strip
EP3920798B1 (en) 2019-02-05 2024-08-14 Ascensia Diabetes Care Holdings AG Apparatus and methods for probing sensor operation of continuous analyte sensing and auto-calibration
US11445944B2 (en) 2019-02-22 2022-09-20 Ascensia Diabetes Care Holdings Ag Methods and apparatus for analyte concentration monitoring using harmonic relationships
CN109884150B (zh) * 2019-03-08 2021-05-14 武汉璟泓科技股份有限公司 一种红细胞积压校正方法及存储介质
US11963763B2 (en) 2019-09-10 2024-04-23 Ascensia Diabetes Care Holdings Ag Methods and apparatus information gathering, error detection and analyte concentration determination during continuous analyte sensing
CN112432988B (zh) * 2020-11-25 2023-03-03 重庆迈联医疗科技有限公司 电化学测试系统的温度校正方法
CN114777888B (zh) * 2022-04-28 2024-09-20 四川泛华航空仪表电器有限公司 一种基于光纤光栅压力传感器液位测量误差补偿修正方法
CN119224239B (zh) * 2024-12-02 2025-04-18 无锡零界净化设备股份有限公司 一种用于离线式浓度监测仪的信号增强方法及平台

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431004A (en) 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4750496A (en) 1987-01-28 1988-06-14 Xienta, Inc. Method and apparatus for measuring blood glucose concentration
US5243516A (en) 1989-12-15 1993-09-07 Boehringer Mannheim Corporation Biosensing instrument and method
US5508171A (en) 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
FR2701117B1 (fr) 1993-02-04 1995-03-10 Asulab Sa Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose.
US5366609A (en) 1993-06-08 1994-11-22 Boehringer Mannheim Corporation Biosensing meter with pluggable memory key
US5352351A (en) 1993-06-08 1994-10-04 Boehringer Mannheim Corporation Biosensing meter with fail/safe procedures to prevent erroneous indications
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6153069A (en) 1995-02-09 2000-11-28 Tall Oak Ventures Apparatus for amperometric Diagnostic analysis
US5582697A (en) 1995-03-17 1996-12-10 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5620579A (en) 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
US5723284A (en) 1996-04-01 1998-03-03 Bayer Corporation Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood
EP0958495B1 (en) 1997-02-06 2002-11-13 Therasense, Inc. Small volume in vitro analyte sensor
US6391558B1 (en) 1997-03-18 2002-05-21 Andcare, Inc. Electrochemical detection of nucleic acid sequences
US6391645B1 (en) 1997-05-12 2002-05-21 Bayer Corporation Method and apparatus for correcting ambient temperature effect in biosensors
US5798031A (en) 1997-05-12 1998-08-25 Bayer Corporation Electrochemical biosensor
CA2294610A1 (en) 1997-06-16 1998-12-23 George Moshe Katz Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods
HU222809B1 (hu) 1997-10-03 2003-10-28 77 Elektronika Műszeripari Kft. Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához
US7494816B2 (en) * 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
EP1042667B1 (en) 1997-12-22 2009-06-17 Roche Diagnostics Operations, Inc. Meter
CA2311487C (en) 1998-05-13 2004-02-10 Cygnus, Inc. Signal processing for measurement of physiological analytes
JP4256588B2 (ja) 1998-05-20 2009-04-22 アークレイ株式会社 統計的手法を用いた電気化学的測定方法および測定装置
US6475372B1 (en) 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
CA2305922C (en) 1999-08-02 2005-09-20 Bayer Corporation Improved electrochemical sensor design
JP3655587B2 (ja) 1999-09-20 2005-06-02 ロシュ ダイアグノスティックス コーポレーション 連続アナライトモニタリング用小型バイオセンサー
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
JP4050434B2 (ja) 1999-11-29 2008-02-20 松下電器産業株式会社 サンプルの弁別方法
US7351323B2 (en) 2001-01-17 2008-04-01 Arkray, Inc. Quantitative analyzing method and quantitative analyzer using sensor
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
AU784254B2 (en) 2001-05-21 2006-03-02 Bayer Corporation Improved electrochemical sensor
US6982178B2 (en) 2002-06-10 2006-01-03 E Ink Corporation Components and methods for use in electro-optic displays
US6797150B2 (en) 2001-10-10 2004-09-28 Lifescan, Inc. Determination of sample volume adequacy in biosensor devices
WO2003034055A1 (en) 2001-10-12 2003-04-24 Arkray, Inc. Concentration measuring method and concentration measuring device
CA2419213C (en) 2002-03-07 2011-06-21 Bayer Healthcare Llc Improved electrical sensor
US6946299B2 (en) 2002-04-25 2005-09-20 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US6964871B2 (en) 2002-04-25 2005-11-15 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
AU2003234944A1 (en) 2002-08-27 2004-03-18 Bayer Healthcare, Llc Methods of Determining Glucose Concentration in Whole Blood Samples
US7132041B2 (en) 2003-02-11 2006-11-07 Bayer Healthcare Llc Methods of determining the concentration of an analyte in a fluid test sample
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
EP1656554B1 (en) 2003-08-21 2018-11-07 AgaMatrix, Inc. Method and apparatus for assay of electrochemical properties
JP4449431B2 (ja) 2003-11-19 2010-04-14 パナソニック株式会社 基質濃度の測定方法
WO2005078437A1 (en) * 2004-02-06 2005-08-25 Bayer Healthcare Llc Electrochemical biosensor
CN1938590B (zh) 2004-04-19 2010-05-05 松下电器产业株式会社 血液成分的测定方法、该方法中使用的生物传感器和测定装置
CA2566495C (en) 2004-05-14 2010-08-17 Yingping Deng Performing hematocrit adjustment in glucose assays
CN102507695B (zh) 2004-10-12 2015-12-02 拜尔健康护理有限责任公司 扩散阻挡层中的浓度测定
GB0428547D0 (en) 2004-12-31 2005-02-09 Euroflow Uk Ltd Methods and apparatus for observing vessel contents
GB0501826D0 (en) 2005-01-28 2005-03-09 Melys Diagnostics Ltd Apparatus for measurement of analyte concentration
TW200641352A (en) 2005-04-08 2006-12-01 Bayer Healthcare Llc Oxidizable species as an internal reference in control solutions for biosensors
US7517439B2 (en) 2005-04-15 2009-04-14 Agamatrix, Inc. Error detection in analyte measurements based on measurement of system resistance
KR101503072B1 (ko) 2005-07-20 2015-03-16 바이엘 헬스케어 엘엘씨 게이트형 전류 측정법
US8404100B2 (en) 2005-09-30 2013-03-26 Bayer Healthcare Llc Gated voltammetry
CA2643163C (en) * 2006-02-27 2020-01-28 Bayer Healthcare Llc Temperature-adjusted analyte determination for biosensor systems
US7966859B2 (en) 2006-05-03 2011-06-28 Bayer Healthcare Llc Underfill detection system for a biosensor
TWI431273B (zh) 2006-05-08 2014-03-21 Bayer Healthcare Llc 生物感測器用之異常輸出偵測系統
KR101040860B1 (ko) * 2006-07-05 2011-06-14 파나소닉 주식회사 액체 시료 측정 방법 및 장치
US20080248581A1 (en) 2007-04-06 2008-10-09 Bayer Healthcare Llc Method for performing correction of blood glucose assay bias using blood hemoglobin concentration
MX2010000971A (es) 2007-07-26 2010-03-01 Home Diagnostics Inc Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
US8101062B2 (en) 2007-07-26 2012-01-24 Nipro Diagnostics, Inc. System and methods for determination of analyte concentration using time resolved amperometry
JP5812603B2 (ja) 2007-12-10 2015-11-17 バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC 勾配ベース補正
CN102239406A (zh) 2008-12-08 2011-11-09 拜尔健康护理有限责任公司 具有信号调节功能的生物传感器系统
US8668819B2 (en) 2009-11-10 2014-03-11 Bayer Healthcare Llc Underfill recognition system for a biosensor
EP3104176B1 (en) 2010-06-07 2018-08-29 Ascensia Diabetes Care Holdings AG Slope-based compensation including secondary output signals

Also Published As

Publication number Publication date
US20170360712A1 (en) 2017-12-21
EP3315123A1 (en) 2018-05-02
EP3315123B1 (en) 2019-08-21
MX2014003015A (es) 2014-05-07
ES2663097T3 (es) 2018-04-11
KR20140063829A (ko) 2014-05-27
TW201314195A (zh) 2013-04-01
JP2014527186A (ja) 2014-10-09
US9775806B2 (en) 2017-10-03
US20130071869A1 (en) 2013-03-21
EP3586831A1 (en) 2020-01-01
EP2758039B1 (en) 2018-01-24
JP6082396B2 (ja) 2017-02-15
TWI600892B (zh) 2017-10-01
EP2758039A1 (en) 2014-07-30
US10646445B2 (en) 2020-05-12
WO2013043839A1 (en) 2013-03-28
MX350696B (es) 2017-09-14

Similar Documents

Publication Publication Date Title
ES2757909T3 (es) Analisis de compensación que incluye señales segmentadas
US10921278B2 (en) Slope-based compensation including secondary output signals
RU2455925C2 (ru) Определение исследуемого вещества с поправкой на температуру для систем биодатчиков
JP6002274B2 (ja) 信号調整を持つバイオセンサシステム
ES2812806T3 (es) Calibración normalizada de determinaciones de la concentración de analito
CN103003692B (zh) 用于生物传感器的剩余补偿
JP2012511160A5 (cg-RX-API-DMAC7.html)
JP7066649B2 (ja) 分析物濃度決定のシステム誤差補償
JP2016517517A5 (cg-RX-API-DMAC7.html)
ES2715407T3 (es) Aproximación progresiva de la concentración de un analito de muestra
ES2697000T3 (es) Compensación basada en pendiente